Clinical Trial Update: Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the combination of selinexor and venetoclax as maintenance therapy after allogeneic hematopoietic stem cell transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Venclexta (venetoclax)
• XPOVIO (selinexor)

Snippet

Sponsor: Ruijin Hospital | Conditions: MDS, AML, Adult | Phase 2 | Status: NOT_YET_RECRUITING